Cannara Biotech Inc. (TSXV: LOVE)

Market Cap	76.52M
Revenue (ttm)	81.75M
Net Income (ttm)	6.44M
Shares Out	90.02M
EPS (ttm)	0.07
PE Ratio	12.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,890
Average Volume	40,055
Open	0.850
Previous Close	0.840
Day's Range	0.820 - 0.850
52-Week Range	0.520 - 1.040
Beta	1.14
RSI	58.38
Earnings Date	Jan 24, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LOVE

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.